New Strong Sell Stocks for January 6th
- Oops!Something went wrong.Please try again later.
- Oops!Something went wrong.Please try again later.
- Oops!Something went wrong.Please try again later.
- Oops!Something went wrong.Please try again later.
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Alaska Air Group, Inc. ALK provides passenger and cargo air transportation services. The Zacks Consensus Estimate for its current year earnings has been revised 26.1% downward over the last 30 days.
Global Blood Therapeutics, Inc. GBT is a clinical-stage biopharmaceutical company. The Zacks Consensus Estimate for its current year earnings has been revised 23.6% downward over the last 30 days.
Horizon Therapeutics Public Limited Company HZNP is a biopharmaceutical company, focuses on researching, developing, and commercializing of medicines that address unmet treatment needs for rare and rheumatic diseases. The Zacks Consensus Estimate for its current year earnings has been revised 14.6% downward over the last 30 days.
Ichor Holdings, Ltd. ICHR engages in the design, engineering, and manufacture of fluid delivery subsystems and components for semiconductor capital equipment. The Zacks Consensus Estimate for its current year earnings has been revised 6.2% downward over the last 30 days.
Kirkland Lake Gold Ltd. KL engages in the acquisition, exploration, development, and operation of gold properties. The Zacks Consensus Estimate for its current year earnings has been revised 3.7% downward over the last 30 days.
View the entire Zacks Rank #5 List.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Horizon Therapeutics Public Limited Company (HZNP) : Free Stock Analysis Report
Alaska Air Group, Inc. (ALK) : Free Stock Analysis Report
Global Blood Therapeutics, Inc. (GBT) : Free Stock Analysis Report
Ichor Holdings, Ltd. (ICHR) : Free Stock Analysis Report
Kirkland Lake Gold Ltd. (KL) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research